The antiproliferative effects of the synthesized compounds were confirmed by a reduction in phosphorylated AKT (p-AKT) expression at 10 μM, indicating an impact on the PI3K/AKT/mTOR signaling pathway, which is crucial for cell cycle regulation and tumor progression. Here, AKT1 is linked to neoplasm.